Memantine for Agitation and Aggression in Severe Alzheimer's Disease

NCT00401167 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: memantine

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]